Background Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a
frequent cause of invasive infections worldwide. Carbapenems are nowadays the most used …

Introduction: Carbapenems have an important place in our antibiotic armamentarium and
have been trusted to effectively treat infections caused by ESBL-producing …

The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–
producing pathogens is recognized globally as one of the most pressing concerns facing the …

The spread of multidrug-resistant Enterobacteriaceae is complicating the treatment of
nosocomial infections. In many parts of the world, resistance to third-generation …

Introduction: The spread of extended-spectrum β–lactamase (ESBL)-producing
Enterobacteriaceae has become a major public health threat worldwide. Area covered: A …

Objectives Carbapenems are first-line agents for severe infections with extended-spectrum
beta-lactamase (ESBL)-producing bacteria. The use of carbapenems, however, is …

Objectives To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …

In this study, the activity of 18 non-carbapenem antibiotics was evaluated against 100
extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBL-Ec) and 50 ESBL …

Background Carbapenems are widely used for the management of bloodstream infections
(BSIs) caused by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL …

The spread of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae
(ESBL-E) is leading to increased carbapenem consumption. Alternatives to carbapenems …